Poop pills plus antibody: a new hope for stubborn gut infections?
NCT ID NCT03829475
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tested whether adding a drug called bezlotoxumab to a fecal transplant (FMT) could better prevent repeat C. diff infections in people with inflammatory bowel disease (IBD). About 61 adults with both IBD and recurrent C. diff were randomly assigned to get FMT plus bezlotoxumab or FMT plus a placebo. Researchers tracked them for 3 months to see who got another C. diff infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.